Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis
Experimental and Clinical Physiology and Biochemistry · 2015
DOI: 10.25040/ecpb2015.02.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Physiology and Biochemistry, 2015. Verfasst von B. KONDRATSKYI und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
KONDRATSKYI, B., NOVAK, V., KONDRATSKYI, Y., KACHMARYK, D., PANAS, O., VYNARCHYK, M., & DERKACH, Y. (2015). Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis. Experimental and Clinical Physiology and Biochemistry. https://doi.org/10.25040/ecpb2015.02.019
Vancouver
KONDRATSKYI B, NOVAK V, KONDRATSKYI Y, KACHMARYK D, PANAS O, VYNARCHYK M, et al. Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis. Experimental and Clinical Physiology and Biochemistry. 2015. doi:10.25040/ecpb2015.02.019
BibTeX
@article{KONDRATSKYI2015,
author = {KONDRATSKYI, B. and NOVAK, V. and KONDRATSKYI, Ya. and KACHMARYK, D. and PANAS, O. and VYNARCHYK, M. and DERKACH, Yu.},
title = {Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis},
journal = {Experimental and Clinical Physiology and Biochemistry},
year = {2015},
doi = {10.25040/ecpb2015.02.019}
}
EUVIMED